Pancreatic Cancer Research

ResearcherPurdue University West LafayetteActive in the last 2 years

Chien‐Chi Lin

Matched on ORCID iD 0000-0002-4175-8796; OpenAlex author ID A5019613511; NIH RePORTER profile ID 9974734. Sources: OpenAlex.

Their work

Papers
10 (first author 4, last author 5)
Trials
0
Grants
2
Labs led
3
Collaborators
8
Papers, trials and grants by year

2013: 1 paper · 2014: 1 paper · 2015: 1 grant · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 grant · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 10

  1. Dynamic granular hydrogels to assess pancreatic cancer cell fate. First author DOI 10.1039/d5bm00997a↗
  2. Click Hydrogels to Assess Stiffness-Induced Activation of Pancreatic Cancer-Associated Fibroblasts and Its Impact on Cancer Cell Spreading. First author DOI 10.1002/cbic.202400955↗
  3. Fast-Relaxing Hydrogels Promote Pancreatic Adenocarcinoma Cell Aggressiveness through Integrin β1 Signaling. Last author DOI 10.1021/acs.biomac.4c01441↗
  4. Viscoelastic stiffening of gelatin hydrogels for dynamic culture of pancreatic cancer spheroids. First author DOI 10.1016/j.actbio.2024.02.010↗
  5. Viscoelastic hydrogels for interrogating pancreatic cancer-stromal cell interactions. Last author DOI 10.1016/j.mtbio.2023.100576↗
  6. Hydrogel Models with Stiffness Gradients for Interrogating Pancreatic Cancer Cell Fate. First author DOI 10.3390/bioengineering8030037↗
  7. Biomimetic and enzyme-responsive dynamic hydrogels for studying cell-matrix interactions in pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.biomaterials.2018.01.012↗
  8. Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment. Co-author DOI 10.1016/j.canlet.2018.08.008↗
  9. Thiol-ene hydrogels as desmoplasia-mimetic matrices for modeling pancreatic cancer cell growth, invasion, and drug resistance. Last author DOI 10.1016/j.biomaterials.2014.08.014↗
  10. Effect of 3D matrix compositions on the efficacy of EGFR inhibition in pancreatic ductal adenocarcinoma cells. Last author DOI 10.1021/bm4004496↗

Grants 2

  1. BRAVE hydrogels for interrogating cell-matrix interactions in pancreatic desmoplasia R01CA227737↗
  2. Adaptable hydrogel platform to study pancreatic cancer R21CA188911↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chun‐Yi Chang · 3 shared papers, 2021–2025 · strength 1.03
  2. Han D. Nguyen · 3 shared papers, 2023–2025 · strength 0.96
  3. Ellen Frahm · 1 shared paper, 2026 · strength 0.63
  4. Melissa L. Fishel · 2 shared papers, 2023–2025 · strength 0.50
  5. Murray Korc · 3 shared papers, 2014–2018 · strength 0.37
  6. Fang‐Yi Lin · 1 shared paper, 2023 · strength 0.22
  7. Hung‐Yi Liu · 1 shared paper, 2018 · strength 0.14
  8. Chang Seok Ki · 2 shared papers, 2013–2014 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.